Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR
deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole …

Introduction A pandemic coronavirus, SARS‐CoV‐2, causes COVID‐19, a potentially life‐
threatening respiratory disease. Patients with cancer may have compromised immunity due …

Background The COVID-19 pandemic has disrupted cancer services globally. New Zealand
has pursued an elimination strategy to COVID-19, reducing (but not eliminating) this …

OBJECTIVE To describe the preliminary clinical outcomes of active surveillance (AS), a new
strategy aiming to individualize the management of early prostate cancer by selecting only …

Abstract Background & Aims There is limited information regarding patients with AIH outside
relatively few large centres. We describe here the presenting features of patients with AIH …

Background With few data regarding treatment and outcome of patients with AIH outside of
large centres we present such a study of patients with AIH in 28 UK hospitals of varying size …

In this centre, patients with pT4b cutaneous melanoma are staged using 18 F-FDG PET–
computed tomography (PET-CT) prior to considering sentinel lymph node biopsy (SLNB) …

COVID-19 caused significant disruption to cancer services around the world. The health
system in Aotearoa New Zealand has fared better than many other regions, with the country …

High-risk primary biliary cholangitis (PBC), defined by inadequate response at one year to
Ursodeoxycholic acid (UDCA), is associated with disease progression and liver …

Aim Cutaneous abscesses are one of the most common acute general surgery
presentations. This study aimed to understand the current practice in the management of …